Picture of Alzamend Neuro logo

ALZN — Alzamend Neuro News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Alzamend Neuro Announces Completion Of A Novel Head Coil By Tesla For Measuring Brain Structure Lithium Levels In Five Upcoming Phase Ii Clinical Trials At Massachusetts General Hospital

Feb 19 (Reuters) - Alzamend Neuro Inc  ALZN.O :
    * ALZAMEND NEURO ANNOUNCES COMPLETION OF A NOVEL HEAD COIL
BY
TESLA FOR MEASURING BRAIN STRUCTURE LITHIUM LEVELS IN FIVE
UPCOMING PHASE II CLINICAL TRIALS AT MASSACHUSETTS GENERAL
HOSPITAL

Source text:  ID:nBw3YrfS7a 
Further company coverage:  ALZN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Alzamend Neuro

See all news